Skip to main content
. 2023 Feb 28;13:1132564. doi: 10.3389/fonc.2023.1132564

Figure 1.

Figure 1

(A) TMA, Hematoxylin and Eosin; (B) TMA, NICD; (C) NICD; (D) Jag1; (E) CD31 non responder patient; (F) CD31 responder patient with NICD and Jag1+.